The Pharmaceutical industry operates within a high-stakes, highly regulated environment where the primary business—developing and distributing products that directly affect public health—generates extreme liability. From the earliest stages of clinical trials to global mass production and commercialization, pharmaceutical companies face a unique and complex risk profile. Insurance is an absolute necessity, serving not just as financial protection against massive Product Liability lawsuits and global supply chain failures, but also as a fundamental tool required for legal operations, securing funding, and meeting contractual obligations with research partners and governments.
The pharmaceutical industry is a rapidly changing global environment, undergoing a massive transition from merely treating diseases to preventing and managing them. Nevertheless, this market continues to discover, develop, and market pharmaceutical drugs to improve the quality of life for patients.
Many experts describe pharmaceutical innovation as having flatlined for nearly a decade. Mostly because the US government has felt the intense financial pressure, leaving little room for developmental momentum. However, sales have continued to climb. But, it only makes sense that this industry is facing challenges adjusting to the new shift in society’s approach to healthcare.
What’s more; is that consumers demand value and measure it according to cost-effectiveness and positive outcomes—a different mindset from days past. Still, with data-driven scientific discovery and medicine, the pharmaceutical industry is geared to navigate the ongoing changes.
Why is Insurance for Pharmaceutical Companies Important?
For pharma companies, insurance isn’t just a protective measure; it’s a critical component of a sustainable business strategy. Here’s why:
Patent Protection
The pharmaceutical industry is not just facing a single patent expiration risk; it is currently entering one of the most severe “patent cliffs” in its history. Between 2025 and 2030, nearly 200 blockbuster drugs are set to lose exclusivity, collectively putting an estimated $230 billion to over $400 billion in global annual sales revenue at risk. This wave of expirations, which includes massive earners like Keytruda, Eliquis, and Stelara, will force a fundamental restructuring of the industry, threatening to halt the upward trajectory of major players and intensifying the need for rapid acquisitions and pipeline innovation.
Momentum
With novel viruses (i.e., SARS-CoV-2) and various health threats surfacing regularly, we all rely on the pharmaceutical industry to help treat these issues. Keeping pace with such threats requires pharmaceutical companies to protect the ground already covered as they forge ahead to new discoveries.
Tax Reforms
Tax Reforms
Pharmaceutical company mergers and acquisitions (M&A) have taken a step back because of recent tax reforms—specifically, the Affordable Care Act (ACA). Many pharmaceutical companies have mounds of cash invested overseas in research and development (R&D) programs. To move forward on any US-related M&A could subject that money to heavy taxation, which might cause more loss than gain in the end.
Advocacy Groups
Patient advocacy groups influence governments and regulators heavily. These organizations lobby for officials to address inequalities for medical care of rare diseases. Naturally, this creates challenges for pharmaceutical companies, forcing them to take competitive risks to develop medicine for these specific diseases. All the while, chronic diseases are monopolizing much of the healthcare budget.
Pharmaceutical Insurance Coverage & Policies
These coverages form the foundation of any risk management program for pharma businesses:
General Liability covers the business against claims of third-party bodily injury (like a slip-and-fall at a manufacturing plant) or property damage resulting from general operations, ensuring that routine accidents don’t halt critical work.
Errors & Omissions (E&O) protects the company from claims alleging financial harm caused by professional errors, such as a mistake in clinical data reporting or failure of a crucial software system used in drug development.
Directors & Officers (D&O) safeguards the personal assets of the company’s leadership from lawsuits related to alleged mismanagement, breach of fiduciary duty, or corporate governance issues, which is critical during clinical trial failures or regulatory scrutiny.
Clinical Trials Liability is mandatory coverage that protects the company (the trial sponsor) against legal liability for bodily injury, illness, or death suffered by human participants during all phases of drug or device testing, enabling research to proceed.
Product Liability is paramount for pharmaceutical companies, covering legal defense costs and settlement payouts for claims alleging injury, illness, or death resulting from the use of a marketed drug due to a defect, improper warning, or contamination.
Intellectual Property (IP) Insurance provides financial backing to cover the exorbitant legal costs of both defending the company against claims of patent infringement by competitors and pursuing legal action to enforce the company’s own valuable patents and trademarks.
The cost of insurance for pharmaceutical companies is highly dependent on a combination of factors related to their size, stage of development, and operational history. Premiums are primarily determined by the company’s size and its stage in the development process, as a firm conducting human clinical trials faces different liabilities than one engaged in mass manufacturing.
Insurers assess the company’s total exposures (the specific risks being insured, such as specialized labs or global distribution) alongside its claims history (the frequency and severity of past losses). Finally, the ultimate price is influenced by the company’s internal practices regarding safety and risk management, as well as the chosen program structure, specifically the amount of the deductible and the company’s overall willingness to assume a portion of the risk itself.
Pharmaceutical Insurance Claims & Examples
Navigating a commercial insurance claim is often challenging, often fraught with confusion and multiple unknown factors. The following four-part series outlines the ins and outs of commercial insurance claims:
The single greatest liability risk is participant injury during clinical trials. Even with rigorous safety protocols, testing new chemical entities or biologics on human subjects carries an inherent risk of adverse events, severe side effects, or death. This risk is covered by Clinical Trials Liability insurance, which is legally required by regulatory bodies (like the FDA) and institutional review boards (IRBs) to ensure the company has the financial means to cover medical expenses and legal defense costs, regardless of fault, if a trial participant is harmed.
Pharmaceutical insurance policies must contain specialized coverage for contamination and spoilage because a vast majority of drug products and critical research materials (like cell cultures, temperature-sensitive biologics, and active ingredients) are highly vulnerable to physical risks. A simple event, such as a power outage, a faulty freezer, or a minor air filtration failure in a clean room, can cause millions of dollars worth of inventory and irreplaceable research samples to be destroyed, requiring specialized Change in Controlled Environment (CICE) and Product Contamination policies to cover the loss and replacement costs.
The primary difference lies in where the injury or damage occurs relative to the product. General Liability covers non-product, operational risks, such as a visitor slipping on a wet floor in your lobby or an employee accidentally damaging property at a vendor’s office. In contrast, Product Liability—which is the single biggest liability for a pharmaceutical company—covers claims for bodily injury or illness that arise after the drug product has left your control and is being used by the patient, such as a severe side effect, a manufacturing defect, or a failure to warn of a known risk. For drug companies, a basic CGL policy may often include some product coverage, but the massive catastrophic risk requires purchasing a robust, specialized Product Liability policy with high limits.
Pharmaceutical Insurance Insights
ARTICLES
Navigating Evolving Risks in the Biotech Industry
The biotech industry thrives on forward thinking and innovative technology—but faces plenty of risks nonetheless. Here’s an industry-wide look.
Biotech Companies: How Your Pipeline Influences Investors
Biotech companies establish pipelines to land the FDA's approval for novel drugs eventually — but the process helps to secure funding, too. Here's how.
Update: We’ve released a new whitepaper examining the Biotech industry. We dive into the insurance landscape, funding, legal climate, and how to approach risk management...
Finding subscription insurance coverage doesn’t have to be painful. We aim to make the purchasing experience as streamlined and intuitive as possible.
1
Get a quote
Use our custom-built digital platform to get quotes fast. We automate clerical tasks that plague traditional insurance brokerages, giving us more time to be responsive and alert to your company’s needs.
2
Pair with a specialist
No two organizations are the same. Our team of coverage experts partners with your team to engineer your risk management strategy, together. We take the time to understand the intricacies of your company to get you the best possible coverage.
3
Stay one step ahead
To do better, you need to know better. With changing political, technological, legal, and economic landscapes, staying ahead of the curve is critical.
Our in-house team is tapped into the latest developments in your industry, proactively ensuring you’re covered.
Schedule Time with a Pharmaceutical Expert
Risk Calibration
Let’s figure out if you’re under- or over-insured and whether your current policies have detrimental gaps.
Identify Cost Savings
We’ll compare your current policies with our extensive benchmarking database to see if your risk and costs have kept pace.
Risk Calibration
Walk away with a detailed plan to manage risk as your company scales — no strings attached.
Why Choose Founder Shield?
Founder Shield is a leading insurance provider that specializes in offering comprehensive coverage for pharmaceutical companies, offering numerous benefits and advantages over traditional insurance providers. Here’s a breakdown of some of the key features and benefits that you’ll enjoy with us:
Benefits of Choosing Founder Shield
Industry Expertise
Founder Shield is focused on protecting rapidly evolving pharmaceutical startups. We ensure that our products are tailored to meet the unique needs of pharma companies.
Customized Solutions
Founder Shield offers bespoke insurance policies that are designed specifically for each client’s needs, ensuring comprehensive coverage that addresses the unique risks associated with pharmaceutical operations.
Fast Quotes
With Founder Shield’s streamlined quoting process, you can receive a personalized quote for your pharmaceutical business insurance quickly, allowing you to make informed decisions fast.
Ease of Use
Founder Shield’s user-friendly digital platform makes it easy to manage your insurance policies, submit claims, and access important documents whenever you need them.
Dedicated Support
Founder Shield provides exceptional customer service, with dedicated account managers who are always available to assist you with any questions or concerns you may have about your insurance coverage.
Scalable Coverage
As your business grows, Founder Shield’s insurance policies can grow with you, ensuring you always have the right level of coverage for your changing needs.
Founder Shield is a preferred choice for pharmaceutical companies because of our specialization in the industry. We offer flexible and customized insurance policies, a speedy quoting process, and exceptional customer service with dedicated account managers.
Great service – proactive, responsive, go beyond what I have expected from previous providers. The team do a wonderful job
Blockchain
Cannabis
Cryptocurrency
Influencers
Micromobility
On-Demand & Shared Economy
On-Demand Delivery
Robotics
SPACs
Web3
AI
E-Commerce
Education Technology
Esports
Fintech
MSPs
SaaS
Startups
Technology
Life Science Risk Management
Biotech
Dietary Supplement & Nutraceutical
FamTech & BabyTech
HealthTech
Pharmaceutical
Virtual Care, TeleHealth, & Telemedicine
Financial Services
Professional Services
Media & Advertising
info@foundershield.com 
28 Liberty Street, New York, NY 10005 
646.854.1058 
Amit Patel
